Is that Elizabeth Holmes who wrote the article?
"In addition, today’s announcement of a binding LOI with Cyclomics (link) positions the combination of cutting-edge technologies to be at the forefront of liquid biopsies (blood tests) for cancer and other diseases."
The article is the worst denial piece I have read.
They attacked Hindenburg but never stated any facts to prove the Hindenburg Report wasn't accurate. Actually, I have read the Hindenburg Report on Mullen several times and didn't find anything inaccurate.
Plus, I had never heard the term shorter attack. The company management seems to be lacking at best.
The good thing is that Serhat Gumrukcu is in Federal Custody. The DOJ could seek the death penalty.
I am fairly certain that the investigation will continue - be careful Dr. Mark Dybul you might be next.
IG
"In addition, today’s announcement of a binding LOI with Cyclomics (link) positions the combination of cutting-edge technologies to be at the forefront of liquid biopsies (blood tests) for cancer and other diseases."
The article is the worst denial piece I have read.
They attacked Hindenburg but never stated any facts to prove the Hindenburg Report wasn't accurate. Actually, I have read the Hindenburg Report on Mullen several times and didn't find anything inaccurate.
Plus, I had never heard the term shorter attack. The company management seems to be lacking at best.
The good thing is that Serhat Gumrukcu is in Federal Custody. The DOJ could seek the death penalty.
I am fairly certain that the investigation will continue - be careful Dr. Mark Dybul you might be next.
IG
The First Casualty of Emotion is Reason.
Recent LNAI News
- Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock • PR Newswire (US) • 05/22/2026 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 01:15:29 PM
- LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT • PR Newswire (US) • 05/20/2026 01:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:46:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:45:41 PM
- CNS Drug Delivery Technologies Are Reshaping Alzheimer's and Biodefense Research • InvestorsHub NewsWire • 05/13/2026 01:00:00 PM
- CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research • GlobeNewswire Inc. • 05/13/2026 12:30:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/11/2026 09:30:26 PM
- Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP • PR Newswire (US) • 05/04/2026 01:35:00 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 05/01/2026 09:18:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 09:17:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 09:30:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 09:00:31 PM
- Lunai Bioworks Unit Signs Preliminary Deal with Geneial on Rare Disease Data Collaboration • IH Market News • 04/15/2026 02:54:51 PM
- Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships • PR Newswire (US) • 04/15/2026 01:10:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/13/2026 09:15:39 PM
- Lunai Bioworks unit secures defense collaboration for AI chemical threat platform • IH Market News • 04/07/2026 01:44:38 PM
- Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion • PR Newswire (US) • 04/07/2026 01:05:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/02/2026 09:01:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:35:01 PM
- Lunai Bioworks to acquire CNS drug delivery platform and Alzheimer’s assets for $20M • IH Market News • 03/26/2026 03:21:42 PM
- Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications • PR Newswire (US) • 03/26/2026 12:50:00 PM
- Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model • PR Newswire (US) • 03/19/2026 01:57:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:46:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:33:21 PM
